Autogenous Vaccines Market

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Market Context

    4.1. Regulatory Scenario

    4.2. Parent Market Analysis

5. Global Autogenous Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

    6.2. Forecast Factors - Relevance & Impact

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

7. Global Autogenous Vaccines  Market Analysis 2014-2018 and Forecast 2019-2029, by Strain Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) & Volume (Mn Units) Analysis By Strain Type, 2014 - 2018

    7.3. Current and Future Market Size (US$ Mn) & Volume (Mn Units) Analysis and Forecast By Strain Type, 2019 - 2029

        7.3.1. Bacterial Strain

        7.3.2. Virus Strain

    7.4. Market Attractiveness Analysis By Strain Type

8. Global Autogenous Vaccines  Market Analysis 2014-2018 and Forecast 2019-2029, by End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2018

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 - 2029

        8.3.1. Veterinary Clinics

        8.3.2. Veterinary Hospitals

        8.3.3. Veterinary Research Institutes

    8.4. Market Attractiveness Analysis By End User

9. Global Autogenous Vaccines  Market Analysis 2014-2018 and Forecast 2019-2029, by Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018

    9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia

        9.3.6. Oceania

        9.3.7. Middle East & Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Autogenous Vaccines  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

    10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        10.3.1.  By Country

            10.3.1.1. U.S.

            10.3.1.2. Canada

        10.3.2. By Strain Type

        10.3.3. By End User

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Strain Type

        10.4.3. By End User

11. Latin America Autogenous Vaccines  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        11.3.1.  By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Rest of Latin America

        11.3.2. By Strain Type

        11.3.3. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Strain Type

        11.4.3. By End User

12. Europe Autogenous Vaccines  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        12.3.1.  By Country

            12.3.1.1. Germany

            12.3.1.2. Italy

            12.3.1.3. France

            12.3.1.4. U.K.

            12.3.1.5. Spain

            12.3.1.6. BENELUX

            12.3.1.7. Russia

            12.3.1.8. Rest of Europe

        12.3.2. By Strain Type

        12.3.3. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Strain Type

        12.4.3. By End User

13. South Asia Autogenous Vaccines  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        13.3.1.  By Country

            13.3.1.1. India

            13.3.1.2. Thailand

            13.3.1.3. Indonesia

            13.3.1.4. Malaysia

            13.3.1.5. Rest of South Asia

        13.3.2. By Strain Type

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Strain Type

        13.4.3. By End User

14. East Asia Autogenous Vaccines  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        14.3.1.  By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

        14.3.2. By Strain Type 

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Strain Type 

        14.4.3. By End User

15. Oceania Autogenous Vaccines  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        15.3.1.  By Country

            15.3.1.1. Australia

            15.3.1.2. New Zealand

        15.3.2. By Strain Type 

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Strain Type 

        15.4.3. By End User

16. Middle East and Africa Autogenous Vaccines  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        16.3.1.  By Country

            16.3.1.1. GCC Countries

            16.3.1.2. Turkey

            16.3.1.3. Northern Africa

            16.3.1.4. South Africa

            16.3.1.5. Rest of Middle East and Africa

        16.3.2. By Strain Type 

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Strain Type 

        16.4.3. By End User

17. Emerging Countries Autogenous Vaccines  Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. China Autogenous Vaccines  Market Analysis

        17.2.1. Introduction

        17.2.2. Market Value Proportion Analysis by Market Taxonomy

        17.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            17.2.3.1. By Strain Type 

            17.2.3.2. By End User

    17.3. India Autogenous Vaccines  Market Analysis

        17.3.1. Introduction

        17.3.2. Market Value Proportion Analysis by Market Taxonomy

        17.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            17.3.3.1. By Strain Type 

            17.3.3.2. By End User

    17.4. Brazil Autogenous Vaccines  Market Analysis

        17.4.1. Introduction

        17.4.2. Market Value Proportion Analysis by Market Taxonomy

        17.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            17.4.3.1. By Strain Type 

            17.4.3.2. By End User

18. Market Structure Analysis

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Deep Dive 

        19.2.1. Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)

            19.2.1.1. Overview

            19.2.1.2. Product Portfolio

            19.2.1.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.1.4. Sales Footprint

            19.2.1.5. Strategy Overview

                19.2.1.5.1. Marketing Strategy

                19.2.1.5.2. Product Strategy

                19.2.1.5.3. Channel Strategy 

        19.2.2. Elanco Animal Health

            19.2.2.1. Overview

            19.2.2.2. Product Portfolio

            19.2.2.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.2.4. Sales Footprint

            19.2.2.5. Strategy Overview

                19.2.2.5.1. Marketing Strategy

                19.2.2.5.2. Product Strategy

                19.2.2.5.3. Channel Strategy 

        19.2.3. Ceva (Ceva Biovac)

            19.2.3.1. Overview

            19.2.3.2. Product Portfolio

            19.2.3.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.3.4. Sales Footprint

            19.2.3.5. Strategy Overview

                19.2.3.5.1. Marketing Strategy

                19.2.3.5.2. Product Strategy

                19.2.3.5.3. Channel Strategy 

        19.2.4. Cambridge Technologies

            19.2.4.1. Overview

            19.2.4.2. Product Portfolio

            19.2.4.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.4.4. Sales Footprint

            19.2.4.5. Strategy Overview

                19.2.4.5.1. Marketing Strategy

                19.2.4.5.2. Product Strategy

                19.2.4.5.3. Channel Strategy 

        19.2.5. Hygieia Biological Laboratories

            19.2.5.1. Overview

            19.2.5.2. Product Portfolio

            19.2.5.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.5.4. Sales Footprint

            19.2.5.5. Strategy Overview

                19.2.5.5.1. Marketing Strategy

                19.2.5.5.2. Product Strategy

                19.2.5.5.3. Channel Strategy 

        19.2.6. Dyntec s. r. o

            19.2.6.1. Overview

            19.2.6.2. Product Portfolio

            19.2.6.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.6.4. Sales Footprint

            19.2.6.5. Strategy Overview

                19.2.6.5.1. Marketing Strategy

                19.2.6.5.2. Product Strategy

                19.2.6.5.3. Channel Strategy 

        19.2.7. Phibro Animal Health Corporation

            19.2.7.1. Overview

            19.2.7.2. Product Portfolio

            19.2.7.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.7.4. Sales Footprint

            19.2.7.5. Strategy Overview

                19.2.7.5.1. Marketing Strategy

                19.2.7.5.2. Product Strategy

                19.2.7.5.3. Channel Strategy 

        19.2.8. Huvepharma, Inc.

            19.2.8.1. Overview

            19.2.8.2. Product Portfolio

            19.2.8.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.8.4. Sales Footprint

            19.2.8.5. Strategy Overview

                19.2.8.5.1. Marketing Strategy

                19.2.8.5.2. Product Strategy

                19.2.8.5.3. Channel Strategy 

        19.2.9. Deltamune

            19.2.9.1. Overview

            19.2.9.2. Product Portfolio

            19.2.9.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.9.4. Sales Footprint

            19.2.9.5. Strategy Overview

                19.2.9.5.1. Marketing Strategy

                19.2.9.5.2. Product Strategy

                19.2.9.5.3. Channel Strategy 

        19.2.10. AniCon Labor GmbH 

            19.2.10.1. Overview

            19.2.10.2. Product Portfolio

            19.2.10.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.10.4. Sales Footprint

            19.2.10.5. Strategy Overview

                19.2.10.5.1. Marketing Strategy

                19.2.10.5.2. Product Strategy

                19.2.10.5.3. Channel Strategy 

        19.2.11. ACE Laboratory Services (Apiam Animal Health)

            19.2.11.1. Overview

            19.2.11.2. Product Portfolio

            19.2.11.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.11.4. Sales Footprint

            19.2.11.5. Strategy Overview

                19.2.11.5.1. Marketing Strategy

                19.2.11.5.2. Product Strategy

                19.2.11.5.3. Channel Strategy 

20. Assumptions and Acronyms Used

21. Research Methodology

---